MiR-145 inhibits the migration and invasion of papillary thyroid carcinoma cells through NF-κB pathway regulation

被引:13
|
作者
Chen, Gengyu [1 ]
Gao, Ying [2 ]
Wang, Gangpu [1 ]
Dai, Guofeng [1 ]
Li Tong [1 ]
机构
[1] Fourth Hosp Jinan City Jinan, Dept Gen Surg 2, 50 Shifan Rd, Jinan 250021, Shandong, Peoples R China
[2] Shandong Univ, Shandong Qianfoshan Hosp, Dept Lab Med, Jinan, Shandong, Peoples R China
关键词
invasion; migration; miR-145; NF-kappa B pathway; papillary thyroid carcinoma; MESENCHYMAL TRANSITION; CANCER STATISTICS; MICRORNA; GROWTH; PROLIFERATION; EXPRESSION; TARGETS;
D O I
10.1002/jcb.29604
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Papillary thyroid carcinoma (PTC) is the most prevalent cancer in the endocrine system, and the number of patients diagnosed with PTC has been increasing rapidly in recent years. Previous studies have reported that miR-145 plays an important role in many kinds of cancers, but its function in PTC remains unclear. In this study, we found that compared to paracancerous tissues, the level of miR-145 expression was significantly downregulated in PTC tissues. When miR-145 is overexpressed, migration and invasion of PTC cells were suppressed in vitro. In addition, we found that miR-145 downregulated the nuclear factor-kappa B (NF-kappa B) pathway in PTC cells. Taken together, our data suggest that miR-145 functions as a tumor suppressor in PTC with the suppressive effect related to downregulation of the NF-kappa B pathway.
引用
收藏
页码:3325 / 3332
页数:8
相关论文
共 50 条
  • [21] Downregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathway
    Zhao, Jun
    Ma, Shi-Tang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (05) : 7388 - 7394
  • [22] miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1
    Li, Enqi
    Zhang, Jinli
    Yuan, Tianxiang
    Ma, Baotong
    TUMOR BIOLOGY, 2014, 35 (08) : 7645 - 7650
  • [23] MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3
    Fu, Songbo
    Ma, Chengxu
    Tang, Xulei
    Ma, Xiaoni
    Jing, Gaojing
    Zhao, Nan
    Ran, Junta
    BIOSCIENCE REPORTS, 2021, 41 (09)
  • [24] RBPJ inhibits the movability of endometrial carcinoma cells by miR-155/NF-κB/ROS pathway
    Xiao, Yufeng
    Wang, Xiaoli
    Dong, Xiping
    Zhang, Yan
    Liu, Haibin
    ONCOTARGETS AND THERAPY, 2019, 12 : 8075 - 8084
  • [25] miR-145 inhibits invasion of bladder cancer cells by targeting PAK1
    Kou, Bo
    Gao, Yang
    Du, Chong
    Shi, Qi
    Xu, Shan
    Wang, Chen-Qing
    Wang, Xinyang
    He, Dalin
    Guo, Peng
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (06) : 846 - 854
  • [26] Downregulation of TACC3 inhibits tumor growth and migration in osteosarcoma cells through regulation of the NF-κB signaling pathway
    Zhao, Congran
    He, Xiaofeng
    Li, Heng
    Zhou, Jihui
    Han, Xiuying
    Wang, Dongjun
    Tian, Guofeng
    Sui, Fuge
    ONCOLOGY LETTERS, 2018, 15 (05) : 6881 - 6886
  • [27] Changes of serum miR-221 and miR-145 levels with papillary thyroid carcinoma and their relationship with invasive activity
    Zhu, Zheng-Cai
    Li, Tao
    Yao, Tian-Qi
    Bi, Jing-Cheng
    Jiao, Liang-He
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (05) : 293 - 301
  • [28] MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2
    Yonglian Huang
    Hengwei Zhang
    Lidong Wang
    Chenxi Liu
    Mingyue Guo
    Hao Tan
    Zhen Liu
    Cancer Cell International, 21
  • [29] MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2
    Huang, Yonglian
    Zhang, Hengwei
    Wang, Lidong
    Liu, Chenxi
    Guo, Mingyue
    Tan, Hao
    Liu, Zhen
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [30] MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells
    Tohidast, Maryam
    Memari, Neda
    Amini, Mohammad
    Hosseini, Seyed Samad
    Jebelli, Asiyeh
    Doustvandi, Mohammad Amin
    Baradaran, Behzad
    Mokhtarzadeh, Ahad
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (11) : 1350 - 1359